Zoloft online research references









  • Sertraline and desmethylsertraline in human breast milk and nursing infants.
  • Effect of sertraline on plasma nortriptyline levels in depressed elderly.
  • The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.
  • Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
  • Sexual dysfunction induced by serotonin reuptake antidepressants.
  • Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex.
  • Treatment of premature ejaculation with sertralin.
  • Preclinical toxicological evaluation of sertraline hydrochloride.
  • Black and white patients response to antidepressant treatment for major depression.
  • Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.
  • Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
  • Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
  • Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
  • Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
  • Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
  • Efficient kinetic resolution in the asymmetric hydrosilylation of imines of 3-substituted indanones and 4-substituted tetralones.
  • Newer antidepressants: a comparison of tolerability in general practice.
  • Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
  • Fluoxetine and sertraline dosages in major depression.
  • CYP2D6 inhibition in patients treated with sertraline.
  • SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
  • HPLC of sertraline and norsertraline in plasma or serum.
  • Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain.
  • Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats.
  • Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release.
  • Prescribing patterns in patients using new antidepressants.
  • Electrochemical behaviour of sertraline at a hanging mercury drop electrode and its determination in pharmaceutical products.
  • Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.
  • Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.
  • Use of sertraline, paroxetine and fluvoxamine by nursing women.
  • Sertraline in child and adolescent psychiatry
  • Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.
  • A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study.
  • Diagnosing and treating depression in the elderly.
  • The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.
  • Long-term costs of treatment for depression: impact of drug selection and guideline adherence.
  • Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
  • Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex.
  • Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline.
  • Fibromyalgia: patient perspectives on symptoms, symptom management, and provider utilization.
  • Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline.
  • Identification of a novel splice variant of heat shock cognate protein 70 after chronic antidepressant treatment in rat frontal cortex.
  • The relationship between pupil diameter and pain by the administration of morphine and antidepressant drugs in mice.
  • Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
  • Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.
  • Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats.
  • The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
  • Evaluating the tolerability of the newer antidepressants.
  • Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.
  • Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission.
  • Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands.
  • Rx drugs
  • The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
  • Rx drugs
  • Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
  • Rx drugs
  • Rx drugs
  • Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
  • Serotonin uptake inhibition: in vivo effect of sertraline in rats.
  • The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
  • Evaluation of the discriminative stimulus and reinforcing effects of sertraline in rhesus monkeys.
  • Feeding pattern studies suggest that d-fenfluramine and sertraline specifically enhance the state of satiety in rats.
  • Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response?
  • Increase of the number of bone marrow T-suppressor cells under inhibition of immunogenesis during changes of the activity of the neuromediator system
  • The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
  • Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
  • Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists.
  • The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
  • Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.
  • Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
  • Reduction of feeding behavior by the serotonin uptake inhibitor sertraline.
  • The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
  • Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord.
  • Lymphocyte glucocorticoid receptor: predictor of sertraline response in adolescent major depressive disorder (MDD).
  • Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
  • Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration.
  • An affinity-modulating site on neuronal monoamine transport proteins.
  • Postpartum syncope.
  • Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
  • Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.
  • Distribution of sertraline in postmortem cases.
  • Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry.
  • Pharmacologic management of obsessive-compulsive disorder.
  • Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands.
  • Serotonin and cardiac morphogenesis in the mouse embryo.
  • Hemodialyzability of sertraline.
  • Effects of serotoninergic agents on downregulation of beta-adrenoceptors by the selective serotonin reuptake inhibitor sertraline.
  • Psychiatrists' responses to failure of maintenance therapy with antidepressants.
  • Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
  • In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
  • Analysis of sertraline-only overdoses.
  • Sertraline overdose.
  • Influence of liver cirrhosis on sertraline pharmacokinetics.
  • Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
  • The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.







    DreamPharm: Herbal and Nutritional supplements online || Hair Million herbal formula for hair loss and hair growth || Antibiotics and prescription medications online literature ||